Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:09 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1873–1896 of 2,211 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Reduced Activity Clear all

Conditions: Behavior, Stress, Anxiety
Interventions: MindBoba, Mindshift CBT; Behavioral
Lead sponsor: IRIS Media Inc; Other
Eligibility: 18 Years and older
Enrollment: 263 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Clostridium Difficile Immunisation, Diphtheria, Diphtheria Immunisation, Pertussis, Tetanus, Tetanus Immunisation
Interventions: Tetanus and Diphtheria Toxoids Adsorbed, Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed onto aluminum hydroxide; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 39 Years · Female only
Enrollment: 399 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Orthopaedic Trauma Infections
Interventions: Highly Sensitive Assays; Diagnostic Test
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Burn Scar, Itch Scarring, Wound
Interventions: Famotidine and 4% topical cromolyn sodium, Placebo; Combination Product · Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 18 Years to 80 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Smoking Cessation, Tobacco Dependence
Interventions: standard cognitive behavioral therapy, Mindfulness Based Cognitive Therapy; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Prostate Cancer, Metastatic Prostate Cancer, Androgen Deprivation Therapy
Interventions: Telerehabilitation Intervention; Other
Lead sponsor: University of Utah; Other
Eligibility: 21 Years and older · Male only
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Sexual Violence
Interventions: RealConsent, Stress and Mood Management; Behavioral
Lead sponsor: Georgia State University; Other
Eligibility: 18 Years to 20 Years · Female only
Enrollment: 881 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Amphetamine Abuse, Amphetamine Dependence, Bipolar Disorder, Major Depressive Disorder
Interventions: Citicoline, Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Binge Eating Behaviour, Eating Disorders, Physical Activity, Functional Magnetic Resonance Imaging (fMRI), Ecological Momentary Assessment, Loss of Control Eating
Interventions: Go/No-go task, Visual food task, Emotion regulation task; Behavioral
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 10 Years to 12 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2030
U.S. locations: 3
States / cities: Los Angeles, California • Richardson, Texas • Fairfax, Virginia

Conditions: Gaucher Disease
Interventions: AVR-RD-02; Drug
Lead sponsor: AVROBIO; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 4
States / cities: San Diego, California • Iowa City, Iowa • Hackensack, New Jersey + 1 more

Conditions: Cigarette Smoking-Related Carcinoma
Interventions: Smoking Cessation Intervention, Smoking Cessation Intervention (control), Medical Device Usage and Evaluation; Behavioral · Other
Lead sponsor: Roswell Park Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Persistent Postsurgical Pain, Breast Cancer Female, Ductal Carcinoma in Situ
Interventions: Acceptance and Commitment Therapy; Behavioral
Lead sponsor: Katherine Hadlandsmyth; Other
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Asthma
Interventions: Active Hand Sanitizer; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 5 Years to 12 Years
Enrollment: 527 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Treatment Resistant Major Depressive Disorder
Interventions: Activa Tremor Control Sys (DBS Implant), Randomized, staggered withdrawal phase; Device · Other
Lead sponsor: Wayne Goodman MD; Other
Eligibility: 21 Years to 70 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Ventilation Therapy; Complications, Diaphragm Disease, Pediatric Respiratory Diseases
Interventions: Computerized Ventilator Protocol, Esophageal Manometry, Respiratory Inductance Plethysmography (RIP), Diaphragm Ultrasound, Maximal Inspiratory Pressure; Other · Diagnostic Test
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 30 Days to 18 Years
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Gout
Interventions: DYV700, Placebo, Colchicine 0.6 mg; Drug
Lead sponsor: Dyve Biosciences, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 284 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Poway, California

Conditions: Suicide, Secure Firearm Storage
Interventions: Peer Engagement and Exploration of Responsibility and Safety, Active Control; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Loneliness
Interventions: HMD AR, 2-D AV; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 60 Years and older
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: HIV/AIDS, Stigma, Social, Emotional Adjustment
Interventions: PLWH intervention, Family member intervention, Healthcare provider intervention; Behavioral
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 1,928 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Columbia, South Carolina

Conditions: Atherosclerosis, Stress, Inflammation
Interventions: Stress Reduction; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 30 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ocular Hypertension, Open Angle Glaucoma
Interventions: Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution, Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution; Drug
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 489 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 30
States / cities: Dothan, Alabama • Phoenix, Arizona • Garden Grove, California + 25 more

Conditions: MCI-AD, Early Stage Alzheimer's Disease, MCI-DLB, Early Stage Dementia With Lewy Bodies
Interventions: Syn-One Test; Diagnostic Test
Lead sponsor: CND Life Sciences; Other
Eligibility: 50 Years to 85 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 12
States / cities: Scottsdale, Arizona • La Jolla, California • Englewood, Colorado + 8 more

Conditions: Heart Failure With Reduced Ejection Fraction
Interventions: LCZ696 200 mg BID, Enalapril 10 mg BID; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 8,442 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 155
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 129 more

Conditions: Acute Coronary Syndrome, Fear Anxiety, Physical Inactivity
Interventions: Reducing Exercise Sensitivity with Exposure Training; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Personal Relevance of Psychotherapy for Asian Americans

Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

BBOT: Bacterial Burden in Ortho Trauma Procedures

Novel Strategies for Reducing Burn Scar Itch

Behavioral Therapy for Reduction in Smoking Craving

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

Efficacy of a Web-based Sexual Violence Risk Reduction Program for Female College Students

A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence

Biobehavioral Mechanisms of Activity and Loss of Control Eating in Children

Lentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02 for Subjects With Type 1 Gaucher Disease

Evaluating the Episodic Future Thinking Intervention for Reducing Cigarette Consumption in Cigarette Smokers

Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and Lumpectomy

Effectiveness of a School-Based Hand Sanitizer Program on Reducing Asthma Exacerbations

DBS of the Lateral Habenula in Treatment-Resistant Depression

Real-time Effort Driven VENTilator Management

Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS)

Reducing Firearm Suicide Among Veterans: Evaluating the Effectiveness of Peer-Delivered Lethal Means Counseling

Reducing Loneliness of Older Adults in Long Term Care Facilities Through Collaborative Augmented Realities

ResIlience-based Stigma REdUction Program ("Rise-up")

Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study

Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

A Diagnostic Test for Dementia With Lewy Bodies

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure

The Reducing Exercise Sensitivity With Exposure Training (RESET) Study